NO179553C - Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre - Google Patents

Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre

Info

Publication number: NO179553C
Authority: NO; Norway
Prior art keywords: 4alkyl; antirhinoviral; hydrogen; compounds; preparation
Prior art date: 1989-05-15

Application number

NO902136A

Other languages

English (en)

Norwegian (no)

Other versions

NO179553B (no

NO902136L (no

NO902136D0 (no

Inventor

Raymond Antoine Stokbroekx

Marcel Jozef Maria Van Der Aa

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-15

Filing date

1990-05-14

Publication date

1996-10-30

1990-05-14 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1990-05-14 Publication of NO902136D0 publication Critical patent/NO902136D0/no

1990-11-16 Publication of NO902136L publication Critical patent/NO902136L/no

1996-07-22 Publication of NO179553B publication Critical patent/NO179553B/no

1996-10-30 Publication of NO179553C publication Critical patent/NO179553C/no

Links

230000002128 anti-rhinoviral effect Effects 0.000 title abstract 2
150000002170 ethers Chemical class 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
125000001475 halogen functional group Chemical group 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000002757 morpholinyl group Chemical group 0.000 abstract 1
125000004193 piperazinyl group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

NO902136A 1989-05-15 1990-05-14 Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre NO179553C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US35169989A	1989-05-15	1989-05-15

Publications (4)

Publication Number	Publication Date
NO902136D0 NO902136D0 (no)	1990-05-14
NO902136L NO902136L (no)	1990-11-16
NO179553B NO179553B (no)	1996-07-22
NO179553C true NO179553C (no)	1996-10-30

Family

ID=23381997

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO902136A NO179553C (no)	1989-05-15	1990-05-14	Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre

Country Status (19)

Country	Link
EP (1)	EP0398426B1 (fr)
JP (1)	JPH0347181A (fr)
KR (1)	KR900018089A (fr)
CN (1)	CN1026489C (fr)
AT (1)	ATE102621T1 (fr)
AU (1)	AU619111B2 (fr)
CA (1)	CA2016741A1 (fr)
DE (1)	DE69007164T2 (fr)
DK (1)	DK0398426T3 (fr)
ES (1)	ES2053078T3 (fr)
FI (1)	FI96948C (fr)
HU (1)	HUT58311A (fr)
IE (1)	IE63537B1 (fr)
IL (1)	IL94383A (fr)
NO (1)	NO179553C (fr)
NZ (1)	NZ233503A (fr)
PT (1)	PT94034B (fr)
RU (1)	RU2057130C1 (fr)
ZA (1)	ZA903663B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5561128A (en) *	1989-05-19	1996-10-01	Hoechst-Roussel Pharmaceuticals, Inc.	N-[(4-(heteroaryl)-1-piperidinyl)alkyl]-10,11-dihydro-5H-dibenz[B,F]azepines and related compounds and their therapeutic utility
US5364866A (en)	1989-05-19	1994-11-15	Hoechst-Roussel Pharmaceuticals, Inc.	Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) *	1989-05-19	1998-07-07	Hoechst Marion Roussel, Inc.	3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
JO1645B1 (en) *	1989-12-26	1991-11-27	شركة جانسين فارماسوتيكا ان. في	Pyridazine compounds are antibacterial viruses
DE4136900C1 (fr) *	1991-11-09	1993-07-29	Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
JPH05255089A (ja) *	1991-12-18	1993-10-05	Sanwa Kagaku Kenkyusho Co Ltd	抗ウイルス剤
WO1994022843A1 (fr) *	1993-03-26	1994-10-13	Schering Corporation	Derives de la morpholine et de la thiomorpholine substitues en position 2 utilises comme antgonistes du gaba¿b?
US5453433A (en) *	1994-05-13	1995-09-26	Sterling Winthrop Inc.	Thiadiazoles and antipicornaviral compositions
DE19743435A1 (de) *	1997-10-01	1999-04-08	Merck Patent Gmbh	Benzamidinderivate
SE9801287D0 (sv) *	1998-04-14	1998-04-14	Astra Ab	Incorporation of active substances in carrier matrixes
RU2242977C1 (ru) *	2003-09-30	2004-12-27	Плотников Евгений Владимирович	Антивирусная и бактерицидная композиция
GB0502046D0 (en) *	2005-02-01	2005-03-09	Sinclair Pharmaceuticals Ltd	Method
CN1887875B (zh) *	2005-06-30	2011-04-06	深圳市东阳光实业发展有限公司	哒嗪胺衍生物及其用于制备小rna病毒抑制剂的用途
WO2013014665A1 (fr) *	2011-07-28	2013-01-31	Mapi Pharma Ltd.	Composés intermédiaires et procédé pour la préparation de lurasidone et de sels de celle-ci

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1243991A (en) *	1968-06-10	1971-08-25	Ici Ltd	Piperidine, morpholine and piperazine derivatives
US4089965A (en) *	1976-03-26	1978-05-16	American Cyanamid Company	Thiazolylphenylguanidines as antirhinovirus agents
US4140785A (en) *	1978-05-08	1979-02-20	E. I. Du Pont De Nemours And Company	N-(benzothienopyrazol)amide antirhinoviral agents
US5001125A (en) *	1984-03-26	1991-03-19	Janssen Pharmaceutica N.V.	Anti-virally active pyridazinamines

1990
- 1990-04-30 NZ NZ233503A patent/NZ233503A/en unknown
- 1990-05-10 AU AU54943/90A patent/AU619111B2/en not_active Ceased
- 1990-05-10 DK DK90201185.7T patent/DK0398426T3/da active
- 1990-05-10 ES ES90201185T patent/ES2053078T3/es not_active Expired - Lifetime
- 1990-05-10 DE DE69007164T patent/DE69007164T2/de not_active Expired - Fee Related
- 1990-05-10 EP EP90201185A patent/EP0398426B1/fr not_active Expired - Lifetime
- 1990-05-10 AT AT90201185T patent/ATE102621T1/de not_active IP Right Cessation
- 1990-05-14 PT PT94034A patent/PT94034B/pt not_active IP Right Cessation
- 1990-05-14 RU SU904743852A patent/RU2057130C1/ru active
- 1990-05-14 IE IE172890A patent/IE63537B1/en not_active IP Right Cessation
- 1990-05-14 FI FI902388A patent/FI96948C/fi not_active IP Right Cessation
- 1990-05-14 HU HU903028A patent/HUT58311A/hu unknown
- 1990-05-14 IL IL9438390A patent/IL94383A/en not_active IP Right Cessation
- 1990-05-14 ZA ZA903663A patent/ZA903663B/xx unknown
- 1990-05-14 CA CA002016741A patent/CA2016741A1/fr not_active Abandoned
- 1990-05-14 NO NO902136A patent/NO179553C/no unknown
- 1990-05-15 KR KR1019900006909A patent/KR900018089A/ko not_active Ceased
- 1990-05-15 JP JP2125261A patent/JPH0347181A/ja active Pending
- 1990-05-15 CN CN90103653A patent/CN1026489C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HU903028D0 (en)	1990-09-28
AU5494390A (en)	1990-11-15
DE69007164D1 (de)	1994-04-14
NZ233503A (en)	1991-06-25
CA2016741A1 (fr)	1990-11-15
CN1026489C (zh)	1994-11-09
IE901728L (en)	1990-11-15
IL94383A (en)	1994-07-31
NO179553B (no)	1996-07-22
JPH0347181A (ja)	1991-02-28
DK0398426T3 (da)	1994-04-05
NO902136L (no)	1990-11-16
EP0398426B1 (fr)	1994-03-09
DE69007164T2 (de)	1994-07-07
RU2057130C1 (ru)	1996-03-27
NO902136D0 (no)	1990-05-14
FI96948B (fi)	1996-06-14
EP0398426A1 (fr)	1990-11-22
KR900018089A (ko)	1990-12-20
PT94034B (pt)	1996-11-29
ZA903663B (en)	1992-01-29
ES2053078T3 (es)	1994-07-16
PT94034A (pt)	1991-01-08
ATE102621T1 (de)	1994-03-15
FI902388A0 (fi)	1990-05-14
CN1047289A (zh)	1990-11-28
AU619111B2 (en)	1992-01-16
HUT58311A (en)	1992-02-28
IE63537B1 (en)	1995-05-17
IL94383A0 (en)	1991-03-10
FI96948C (fi)	1996-09-25

Publication	Publication Date	Title
FI101624B1 (fi)	1998-07-31	Menetelmä terapeuttisesti käyttökelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote
PT89047A (pt)	1988-12-01	Processo para a preparacao de derivados de piridazinamina
NO179553C (no)	1996-10-30	Analogifremgangsmåte for fremstilling av antirhinovirale alkylfenoletre
ATE56972T1 (de)	1990-10-15	N-((4-piperidinyl)-alkyl>-substituierte bicyclische kondensierte oxazol- und thiazolamine.
FI893701A0 (fi)	1989-08-04	Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
DE69007330D1 (de)	1994-04-21	Antirhinovirale Piperidinyl-, Pyrrolidinyl- und Piperazinyl-Alkylphenolether.
NO891176D0 (no)	1989-03-17	Fremstilling av antivirale tetrahydroimidazo(1,4)benzodiazepin-2-oner.
PT94036A (pt)	1991-01-08	Processo para a preparacao de piridazinaminas anti-rinovirais
FI894125A0 (fi)	1989-09-01	Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi